Silastic catheters for home antibiotic therapy in patients with cystic fibrosis

European Journal of Pediatrics

Volumn 156, Issue 3, 1997, Pages 209-211

  Buck, C ^a   Holl, R ^a   Kohne, E ^a   Wolf, A ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Cystic fibrosis; Intravenous antibiotic home therapy; Pseudomonas aeruginosa infection; Silastic catheter

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; PIPERACILLIN; TAZOBACTAM; TEICOPLANIN; TOBRAMYCIN;

ADOLESCENT; ADULT; ARTICLE; CATHETER; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DRUG THERAPY, COMBINATION; EQUIPMENT FAILURE; FEMALE; HOME INFUSION THERAPY; HUMANS; MALE; PNEUMONIA, BACTERIAL; PSEUDOMONAS INFECTIONS; SILICONE ELASTOMERS;

EID: 0031045330     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050585     Document Type: Article

References (10)

1. Dietrich KA, Lobas JG (1988) Use of a single silastic iv catheter for cystic fibrosis pulmonary exacerbations. Pediatr Pulmonol 4:181-184
2. Durand M, Ramanathan R, Martinelli B, Tolentino M (1986) Prospective evaluation of percutaneous central venous silastic catheters in newborn infants with birth weights of 510 to 3920 grams. Pediatrics 78:245-250
3. Garland JS, Dunne M, Havens P, Hintermeyer M, Bozzette MA, Bromberger T, Wincek J, Seavers M (1992) Peripheral intravenous catheter complications in critically ill children: a prospective study. Pediatrics 89:1145-1150
4. Harms K, Herting E, Kron M, Schiffmann H, Schulz-Ehlbeck H (1995) Randomized, controlled trial of amoxicillin prophylaxis for prevention of catheter-related infections in newborn infants with central venous silicone elastomer catheters. J Pediatr 127:615-619
5. Maki DG (1982) Infections associated with intravascular lines. In: Remington JS, Swartz MN (eds) Current clinical topics in infectious disease. McGraw-Hill Book Company, New York, pp 309-355
6. Morris JB, Occhionero ME, Gauderer MWL, Stern RC, Doershuk CF (1990) Totally implantable vascular access devices in cystic fibrosis: a four-year experience with fifty-eight patients. J Pediatr 117:82-85
7. Ramsey BW, Boat TF (1994) Outcome measures for clinical trials in cystic fibrosis. J Pediatr 124:177-192
8. Regelmann WE, Elliott GR, Warwick WJ, Clawson CC (1990) Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone. Am Rev Respir Dis 141:914-921
9. Szaff M, Hoiby N, Flensborg EW (1983) Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand 72:651-657
10. Williams J, Smith HL, Woods CG, Weller PH (1988) Silastic catheters for antibiotics in cystic fibrosis. Arch Dis Child 63:658-659